DI
BPMC

Disciplined Investments’s Blueprint Medicines BPMC Stock Holding History

Disciplined Investments’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 1652
2022
Q3 		$0 Sell
1
-4
-80% -$257 ﹤0.01% 1255
2022
Q2 		$0 Sell
5
-2
-29% -$117 ﹤0.01% 1281
2022
Q1 		$0 Buy
+7
New +$502 ﹤0.01% 1355

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Disciplined Investments's BPMC Position: Q4 2022 in Review

Disciplined Investments sold out of Blueprint Medicines (BPMC) in Q4 2022, closing a stake of 1 share.

Disciplined Investments first reported a position in BPMC in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 223 funds tracked by Wall St. Rank hold BPMC as of Q4 2022.

  • Disciplined Investments reported no remaining Blueprint Medicines position as of Q4 2022 after selling out during the quarter.
  • Disciplined Investments sold 1 Blueprint Medicines share in Q4 2022.
  • Disciplined Investments first reported a position in Blueprint Medicines in Q1 2022 and held it in 3 quarters.
  • Disciplined Investments's Blueprint Medicines position peaked at $0 in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2022.

Based on Disciplined Investments's 13F filing for Q4 2022, filed 2 Feb 2023.